Exploring Patient Experiences with Genetic Therapy in the Era of Molecular Medicine
Main Article Content
Abstract
The field of health communication has witnessed growing interest in the role of digital media in interactions between medical practitioners and patients. While much is known about the technical aspects of digital communication, there remains a limited understanding of the lived experiences and subjective meanings these interactions hold for individuals involved, explored through a phenomenological approach.This study seeks to address this gap by exploring how healthcare professionals and patients perceive and experience digital communication tools, such as WhatsApp and telemedicine apps. Using a phenomenological approach, we investigate these experiences to uncover the underlying essence of their interactions in the context of health communication. Through in-depth interviews with healthcare practitioners and patients, key themes emerged related to trust, accessibility, and the impact of digital tools on the doctor-patient relationship. The findings suggest that while digital tools facilitate communication, they also introduce challenges in building trust and maintaining personal connection. These insights offer valuable implications for improving digital communication strategies and suggest avenues for future research on the integration of digital technologies in healthcare settings.
Article Details
Section
References
Balfoort, B. M., Van Den Broeck, F., Brands, M. M., van Karnebeek, C. D., Bergen, A. A., van den Born, L. I., Houtkooper, R. H., Wagenmakers, M. A. E. M., De Zaeytijd, J., Leroy, B. P., Boon, C. J. F., & Diederen, R. M. H. (2024). A cohort study of 19 patients with gyrate atrophy of the choroid and retina (GACR). Graefe’s Archive for Clinical and Experimental Ophthalmology, 262(11), 3589–3596. Scopus. https://doi.org/10.1007/s00417-024-06540-8
Bhoopalan, S. V., Suryaprakash, S., Sharma, A., & Wlodarski, M. W. (2023). Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: State of the art and science. Frontiers in Oncology, 13. Scopus. https://doi.org/10.3389/fonc.2023.1236038
Compton, D. R., DeMarco, S. J., & Yalamanchili, P. (2023). AAV2-hAADC (Eladocagene Exuparvovec) Biodistribution and Expression: Superiority of Intraputaminal versus Intracerebroventricular and Intrathecal (Lumbar) Routes of Administration. International Journal of Toxicology, 42(2), 135–145. Scopus. https://doi.org/10.1177/10915818221144424
Dimitriu, C., Martignoni, M. E., Bachmann, J., Fröhlich, B., Tintarescu, G., Buliga, T., Lica, I., Constantinescu, G., Beuran, M., & Friess, H. (2005). Clinical impact of cachexia on survival and outcome of cancer patients. Romanian Journal of Internal Medicine = Revue Roumaine de Médecine Interne, 43(3–4), 173–185. Scopus.
Douglas, M. R. (2013). Gene therapy for Parkinson’s disease: State-of-the-art treatments for neurodegenerative disease. Expert Review of Neurotherapeutics, 13(6), 695–705. Scopus. https://doi.org/10.1586/ern.13.58
Franchini, M. (2014). Current management of hemophilia B: Recommendations, complications and emerging issues. Expert Review of Hematology, 7(5), 573–581. Scopus. https://doi.org/10.1586/17474086.2014.947955
He, Z., Li, Y., Zhao, X., & Li, B. (2022). Dravet syndrome: Advances in etiology, clinical presentation, and treatment. Epilepsy Research, 188. Scopus. https://doi.org/10.1016/j.eplepsyres.2022.107041
Himmelreich, N., Montioli, R., Bertoldi, M., Carducci, C., Leuzzi, V., Gemperle, C., Berner, T., Hyland, K., Thöny, B., Hoffmann, G. F., Voltattorni, C. B., & Blau, N. (2019). Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook. Molecular Genetics and Metabolism, 127(1), 12–22. Scopus. https://doi.org/10.1016/j.ymgme.2019.03.009
Lacy, G. D., Abalem, M. F., Musch, D. C., & Jayasundera, K. T. (2020). Patient-reported outcome measures in inherited retinal degeneration gene therapy trials. Ophthalmic Genetics, 41(1), 1–6. Scopus. https://doi.org/10.1080/13816810.2020.1731836
Nguyen, Q. M., Dupré, P.-F., Haute, T., Montier, T., & d’Arbonneau, F. (2023). Suicide gene strategies applied in ovarian cancer studies. Cancer Gene Therapy, 30(6), 812–821. Scopus. https://doi.org/10.1038/s41417-023-00590-6
Sinn, P. L., Anthony, R. M., & McCray Jr., P. B. (2011). Genetic therapies for cystic fibrosis lung disease. Human Molecular Genetics, 20, R79–R86. Scopus. https://doi.org/10.1093/hmg/ddr104
Szöőr, Á., Szöllősi, J., & Vereb, G. (2021). From antibodies to living drugs: Quo vadis cancer immunotherapy? Biologia Futura, 72(1), 85–99. Scopus. https://doi.org/10.1007/s42977-021-00072-6
Wilton-Clark, H., & Yokota, T. (2022). Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot. Genes, 13(2). Scopus. https://doi.org/10.3390/genes13020257
Worth, A. J., & Thrasher, A. J. (2015). Current and emerging treatment options for Wiskott-Aldrich syndrome. Expert Review of Clinical Immunology, 11(9), 1015–1032. Scopus. https://doi.org/10.1586/1744666X.2015.1062366
Zhang, W., Jiao, Y., Zhang, Z., Zhang, Y., Yu, J., & Gu, Z. (2024). Transdermal gene delivery. Journal of Controlled Release, 371, 516–529. Scopus. https://doi.org/10.1016/j.jconrel.2024.06.013